Yardley, PA, United States of America

Tasir Shamsul Hague

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tasir Shamsul Hague. Retrieved from https://idiyas.com/inventor/tasir-shamsul-hague

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tasir Shamsul Hague

Introduction

Tasir Shamsul Hague is an accomplished inventor based in Yardley, PA, known for his contributions to the field of pharmaceutical compounds. His work focuses on developing innovative solutions for treating inflammatory and autoimmune diseases.

Latest Patents

Hague holds a patent for [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds. This patent discloses compounds of Formula (I) or a salt thereof, wherein R, R, R, R, R, m, n, and p are defined. The compounds are recognized for their potential as inhibitors of signaling through Toll-like receptors 7, 8, or 9. Additionally, the patent outlines pharmaceutical compositions that include these compounds, emphasizing their utility in medical treatments.

Career Highlights

Tasir Shamsul Hague is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His role at the company allows him to contribute significantly to research and development in the pharmaceutical industry.

Collaborations

Hague has collaborated with notable colleagues, including Alaric J Dyckman and Dharmpal S Dodd, enhancing the innovative efforts within his team.

Conclusion

Tasir Shamsul Hague's work exemplifies the impact of innovative research in pharmaceuticals, particularly in addressing complex health issues. His contributions continue to pave the way for advancements in treatment options for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…